Related Research News Retatrutide and Erectile Dysfunction: What the Evidence Shows A report titled "Does Retatrutide Cause Erectile Dysfunction?" from FC Bayern, dated August 1, 2026, addresses a common question about the investigational obesity drug
This integrated approach enables synergistic glucose-lowering and weight reduction effects that exceed those achieved by selective incretin agonism alone
Harpreet Tsui, DO, an internal medicine and obesity specialist, explained, We know that abdominal fat releases pro-inflammatory adipokines, increasing systemic inflammation that can trigger or worsen autoimmune diseases
Zepbound (tirzepatide) is an FDA-approved once-weekly injectable medication for weight loss in adults with obesity or overweight and one or more weight-related health conditions
Although 10 nM BCTC blocked the CAP-induced TRPV1 currents, 20 nM BCTC did not significantly potentiate this TRPV1-inhibiting effect (Fig
Our team can assist in navigating these insurance intricacies